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Background: Interleukin-8 (IL-8) and neutrophil elastase (NE) are commonly measured markers of inflammation in bronchoalveolar lavage (BAL)
fluid from patients with cystic fibrosis. Longitudinal analysis assumes uniform stability during storage, however the effect of extended low-
temperature storage on these markers remains unclear.
Methods: BAL fluid from 104 children with cystic fibrosis was assayed for IL-8 and NE after storage at 4 °C for 7 days and −80 °C for up to
6 years and compared with the initial assays performed soon after collection.
Results: IL-8 levels were stable after any measured length of time at −80 °C or 4 °C. NE levels were stable for 6 months at −80 °C but decreased
beyond that or after 7 days at 4 °C.
Conclusions: Our data support the stability of IL-8 in BAL stored at −80 °C for prolonged periods. NE in BAL decreases with storage and should
be assayed as soon as practical after collection.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Inflammation; Children; Bronchoalveolar lavage1. Introduction
Cytokines are produced by immune cells such as lymphocytes
and macrophages and are responsible for immune cell signalling.
Structurally, the majority are composed of low molecular weight
polypeptides which may be distinguished by their function and
origin. One cytokine of clinical relevance is interleukin-8 (IL-8), a
chemotactic cytokine that recruits and activates neutrophils to
assist in the inflammatory response. IL-8 has been shown to be
elevated in selected tissues from patients with conditions such as
psoriasis, periodontal disease and cystic fibrosis [1–3]. As a⁎ Corresponding author. Telethon Institute forChildHealthResearch, POBox 855,
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doi:10.1016/j.jcf.2010.06.002relatively short and simple protein, it is potentially less susceptible
to environmental degradation than larger polypeptides.
Activated neutrophils release a variety of products, including
enzymes. Neutrophil elastase (NE) is a protease capable of
breaking down bacterial membrane proteins and contributes to
bacterial killing. NE can also contribute to lung disease if the
amount exceeds the lung's anti-protease defences due to the
indiscriminate destruction of elastin and other such proteins
present in connective tissue. In cystic fibrosis, NE exaggerates
the effects of IL-8 to produce a more aggressive neutrophilic
response to inflammation [4]. Like IL-8, it is uncomplicated in
structure, and likely to exhibit integrity under storage conditions.
IL-8 and NE both serve as reliable markers of inflammation
in patients with cystic fibrosis [3], and can readily be detected in
samples of bronchoalveolar lavage (BAL) fluid. As part of thed by Elsevier B.V. All rights reserved.
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Fibrosis (AREST CF: www.arestcf.org) program in Perth and
Melbourne, infants and children undergo annual bronchoscopy
and bronchoalveolar lavage for microbiological surveillance
and to assess inflammation. Samples of BAL fluid are analysed
for correlations between inflammatory marker levels and other
clinical and laboratory readings.
The accurate comparison of analyte concentrations over time
is best achieved by simultaneous measurement under identical
conditions. The nature of the laboratory setting and the
infrequency of clinical sampling mean that this is usually not
an effective use of time or resources. Freezing at the time of
collection allows for uniform treatment of samples and stable
preservation of their content until they can be assayed in larger
batches to reduce inter-assay variation. Refrigerated storage,
while not a suitable long-term option, can provide more
flexibility for analysis by slowing the degradation of a sample
and allowing any work to be done over the course of several
days. Previous studies have demonstrated that some cytokines
are more susceptible to degradation in storage than others.
Cytokine degradation has been reported in serum samples
stored at 4 °C, −20 °C and −70 °C for such markers as IL-10,
while TNF-α and IL-6 are stable at 4 °C for up to 6hours and
21 days respectively [5,6]. To date, no studies have examined
cytokine degradation in BAL, or degradation for time periods
greater than a few weeks.
The aim of the present study was to determine the effects of
storage conditions on IL-8 and NE levels, with the hypothesis
that storage of BAL supernatants would not cause significant
degradation. Samples were stored, after routine collection, in
both refrigerated (4 °C) and deep-freeze (−80 °C) conditions
prior to assaying. Refrigeration at 4 °C reflected the use of
transitional storage conditions typical of laboratory practice
requiring continuous work across several days, whereas
freezing at −80 °C better represented long-term archival
collection.2. Methods
2.1. Study population
Children attending the cystic fibrosis clinics at Princess
Margaret Hospital for Children, Perth or the Royal Children's
Hospital, Melbourne, Australia provided samples for this study.
These children were participating in the AREST CF early
disease surveillance program which consists of assessment soon
after diagnosis (average age 3 months) and annually until the
age of 6 years [7]. At each assessment lung function is measured
using age-appropriate techniques and a Chest computed
tomography scan and BAL are performed under general
anaesthesia. All BALs were performed while the child was
clinically stable and fit for general anaesthesia. Details about the
AREST CF program are available from www.arestcf.org.
The AREST CF surveillance program was approved by the
Human Ethics Committees at the Princess Margaret Hospital for
Children, Perth and at the Royal Children's Hospital,Melbourne. Informed written consent was obtained prior to
each procedure.2.2. Sample collection
Flexible bronchoscopy was performed via a laryngeal mask
under general anaesthesia. Three separate aliquots of normal
saline (1 ml/kg) were instilled and retrieved from the right
middle lobe bronchus. The first aspirate was sent for
microbiological analysis with the second and third sample
pooled for inflammatory analysis. At the time of original
collection BAL was kept on ice and processed within one hour.
Samples were centrifuged at 300 g after which cell-free
supernatants were aliquoted and stored at −80 °C. Melbourne
samples were transported frozen to Perth for storage and
subsequent assay.
Aliquots from 146 BAL samples, collected from 104
children with CF over a six year period, were available for
this study. Limits on individual sample volumes restricted a
complete investigation of all archival aliquots.2.3. Cytokine and elastase assays
IL-8 levels were determined using a commercial assay kit in
accordance with the manufacturers' protocol (BD OptEIA, BD
Biosciences, San Diego, CA, USA). Levels were measured as
previously described [8]. Briefly, 50 μl of each sample was added
in duplicate to a 96-well plate, along with 50 μl of a human
neutrophil elastase standard (Calbiochem, Merck Group, Darm-
stedt, Germany) serially diluted from 25 u/ml to 0.02 u/ml in
0.2 MTris pH8.0.A 100 mMsolution of n-methoxysuccinyl-ala-
ala-pro-val p-nitroanilide (Sigma Aldrich Australia, Castle Hill,
NSW, Australia) in 1-methyl-2-pyrrolidinone was diluted to
1 mM in 0.2 M Tris pH 8.0, and 5 μl was added to each well.
Absorbance was read immediately on a Wallac Victor 3
spectrophotometer (PerkinElmer, Shelton, CT, USA) at 405 nm
before incubation at 37 °C. Subsequent readingswere taken every
10 min and subtracted from the initial to determine enzyme
activity. All ELISA and activity assay plates included a sample
from a separate subject with known elevated IL-8 and NE levels
as a positive control. Each sample was assayed for IL-8 and NE
within one month of initial storage as part of routine testing (t=0).
All assays were performed in the same laboratory (Perth) by
qualified laboratory personal following standardized operating
procedures. For evaluation of the stability of IL-8 at −80 °C, a
second aliquot of each sample was thawed and assayed after
t=6 months, 2, 4 and 6 years of storage at −80 °C. No samples
had previously been thawed. Neutrophil elastase was assayed
after t=6 months, 2 and 4 years storage at−80 °C. For evaluation
of stability at 4 °C, all thawed samples with sufficient volume
remaining were re-assayed after one week of refrigerated storage.
The IL-8 assays were sensitive to 0.02 ng/ml with an inter-assay
coefficient of variation of 10.22%. The NE assays were sensitive
to 0.05 μg/ml with an inter-assay coefficient of variation of
7.99%. Samples below the detection limit of either assay were
assigned a value equal to half the minimum limit.
Table 1
Interleukin-8 (IL-8) concentration in BAL fluid after storage at −80 °C and
4 °C.
Follow up time Storage time Initial Follow up p value
6 years a n 10 10
IL-8 ng/ml [median] 1.55 2.08 0.93
IL-8 ng/ml [range] (0.05, 66.0) (0.18, 21.5)
IL-8 ng/ml [25–75%] [0.85–3.11] [0.33–3.82]
Mean difference −0.33
95% LOAb −6.04, 5.38
4 years a n 32 32
IL-8 ng/ml [median] 1.47 1.37 0.36
IL-8 ng/ml [range] 0.02, 29.5 0.02, 29.60
IL-8 ng/ml [25–75%] 0.50–3.88 0.60–4.12
Mean difference −0.24
95% LOAb −3.55, 3.06
2 years a n 32 32
IL-8 ng/ml [median] 0.49 0.94 0.52
IL-8 ng/ml [range] 0.02, 107.50 0.03, 74.0
IL-8 ng/ml [25–75%] 0.15–17.75 0.32–4.80
Mean difference 3.45
95% LOAb −8.89 15.8
6 months a n 32 32
IL-8 ng/ml [median] 1.05 1.03 0.005
IL-8 ng/ml [range] 0.02, 5.75 0.05, 7.40
IL-8 ng/ml [25–75%] 0.20–2.08 0.29–2.56
Mean difference −0.27
95% LOAb −1.55, 1.02
7 days c n 91 91
IL-8 ng/ml [median] 1.16 1.31 0.16
IL-8 ng/ml [range] 0.02, 74.00 0.03, 65.00
IL-8 ng/ml [25–75%] 0.37–3.20 0.47–3.26
Mean difference −0.24
95% LOAb −4.95, 4.46
Data after each storage interval were compared to the values obtained from an
aliquot of the same sample measured approximately one month after collection.
a Samples stored at −80 °C.
b LOA, limits of agreement.
c Samples stored at 4 °C.
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The mean bias and limits of agreement (1.96⁎SD of difference
between 2 measurements) were calculated for samples tested
6 months, 2, 4 and 6 years apart according to the methods of Bland
and Altman with comparisons made using Wilcoxon signed rank
tests. Graphs and analyses were performed using GraphPad.




Samples were selected for this study if they fell into the time
frame, i.e. the initial test date allowed for re-analysis after
6 months, 2, 4 or 6 years of storage, and if sufficient volume
was available for repeat testing. 146 samples collected from 104
children (34.6% male), with a mean age of 3.3 years (range 0.1–
8.4 years) met these criteria.
3.2. Storage at −80 °C
Storage at −80 °C for a period of 2, 4 or 6 years did not result
in clinically significant alterations in the concentrations of IL-
8 in BAL (Table 1). In particular, no sample went from having a
detectable level of IL-8 when first tested to being below the
limit of detection after storage. At each time point the group
median concentration was similar to the values obtained on the
initial analysis. The only storage interval associated with a
statistically significant decrease in IL-8 was 6 months [1.05
(0.02–5.75)ng/ml and 1.03 (0.05–7.40)ng/ml, p=0.005]. No
systematic bias was observed for IL-8 after any storage interval
at −80 °C (Fig. 1).
Levels of NE in BAL appeared to be affected more by long-
term storage with a significant decrease after storage at −80 °C
for 2 and 4 years (p=0.017 and pb0.0001 respectively), but not
after storage for 6 months (p=0.151) (Table 2). All paired
samples were concordant for the presence of NE activity.
Twenty-six of the samples were at or below the minimum
detection limit of the assay at both measured time points. No
sample that had detectable levels of NE when first analysed
became “undetectable” after storage and none that were initially
“undetectable” became “datable” after storage. No systematic
bias in between test repeatability for NE levels after any storage
interval at −80 °C was observed (Table 2) (Fig. 2).
3.3. Storage at 4 °C
The median concentration of IL-8 was similar between the
initial measurement and after storage for 7 days at 4 °C
(Table 1). The Bland–Altman analysis showed a bias of
−0.24 ng/ml, with 95% limits of agreement of −4.95 to 4.46
for repeated analysis of IL-8 after storage at 4 °C (Fig. 3). NE
appeared to be more influenced by storage at 4 °C for 7 days,
with a significant decrease in group mean concentration
(Table 2) and 25 samples that had detectable levels initiallyfalling below the limit of detection. The Bland–Altman
analysis showed a bias of 0.44 ng/ml, with 95% limits of
agreement of −1.17 to 2.06 (Fig. 3).
4. Discussion
The results from the present study demonstrate that IL-
8 concentrations in BAL do not change substantially after long-
term storage at −80 °C for periods up to 6 years. NE in BAL is
more vulnerable to long-term storage but storage for up to
6 months at −80 °C does not result in substantial loss of
activity. Short-term storage of BAL at 4 °C for 7 days does not
result in a decrease in IL-8 concentrations but does result in a
decrease in levels NE.
Previous studies have demonstrated the robust nature of
protein markers in biological samples to handle storage
conditions. Desmosines in urine exhibit appreciable recovery
after storage and repeated freeze–thaw cycles at −70 °C [9], as
do lipocalins [10]. Urinary markers of styrene exposure have
Fig. 2. Bland–Altman plot of NE concentrations for samples stored at −80 °C.
Samples stored at −80 °C for 6 months, 2 and 4 years. No data for NE was
available beyond four years. The mean bias (middle broken line) was −0.11,
0.06 and 0.13 for each group respectively. The limits of agreement (upper and
lower broken lines) were (1.15, −1.37), (3.16, −3.05) and (0.94, −0.68) for each
group respectively.
Fig. 1. Bland–Altman plot of IL-8 concentrations for samples stored at −80 °C.
Samples stored at −80 °C for 6 months, 2, 4 and 6 years. The mean bias (middle
broken line) was −0.27, 3.45, −0.24 and −0.33 for each group respectively. The
limits of agreement (upper and lower broken lines) were (1.02,−1.55), (15.8,−8.89),
(3.06, −3.55) and (5.38, −6.04) for each group respectively.
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[11]. Similarly, markers in cerebrospinal fluid [12], pleural fluid
[13] and sera [5,9,14] are also suitable for safe storage at−80 °C,
while the reverse seems true of those in cervical mucous, where
snap-freezing can cause significant degradation [15].
Inflammatory cytokines in serum such as TNF-α and IFN-γ
have been shown to remain stable for up to 20 days in both
refrigerated and frozen conditions [16]. Others such as IL-6, IL-10
and CC16 have significant stability estimated for several yearsTable 2
Neutrophil elastase (NE) concentration in BAL fluid after storage at −80 °C and
4 °C.
Follow up time Storage time Initial Follow up p value
4 years a n 28
NE μg/ml [median] 0.10 0.08 b0.0001
NE μg/ml [range] 0.10, 4.12 0.08, 3.90
NE μg/ml [25–75%] 0.10–0.10 0.08–0.08
Mean difference 0.13
95% LOAb −0.68, 0.94
2 years a n 32
NE μg/ml [median] 0.19 0.13
NE μg/ml [range] 0.07, 102.80 0.13, 70.80
NE μg/ml [25–75%] 0.19–2.98 0.07–1.98
Mean difference 0.06
95% LOAb −3.05, 3.16
6 months a n 32
NE μg/ml [median] 0.30 0.04
NE μg/ml [range] 0.14, 2.40 0.04, 4.08 0.151
NE μg/ml [25–75%] 0.14–0.78 0.02–1.11
Mean difference −0.11
95% LOAb −1.37, 1.15
7 days c n 36
NE μg/ml [median] 0.35 0.16 b0.0001
NE μg/ml [range] 0.20, 3.86 (0.16, 3.65
NE μg/ml [25–75%] 0.20–0.79 [0.16–0.16
Mean difference 0.44
95% LOAb −1.17, 2.06
Data after each storage interval were compared to the values obtained from an
aliquot of the same sample measured approximately one month after collection.
a Samples stored at −80 °C.
b LOA, limits of agreement.
c Samples stored at 4 °C.when stored at −70 °C [5]. The present study is the first to
examine the effect of storage on the stability of IL-8 and NE in
BAL.We have found IL-8 to be stable for up to 6 years in storage
at −80 °C, though there is a conflicting trend suggested by the
6 month group. This can be attributed to the high number of
samples that were close to theminimum detection limit at both the
initial and 6 month measurement.
The cytokines IL-6, IL-10 and CC16 in serum have all been
shown to maintain on or about perfect recovery after 4 °C
storage for up to 21 days [5]. Our data demonstrate that IL-8 in
BAL is also stable at 4 °C for 7 days. Taken together, these dataFig. 3. Bland–Altman plot of IL-8 and NE concentration for samples stored at
−4 °C. Samples were tested after one week at 4 °C. a Indicates the change in IL-
8 concentration with a mean bias (middle broken line) of −0.24, and limits of
agreement (upper and lower broken lines) of 4.46 and −4.96 respectively. b
Indicates the change in NE concentration. The mean bias was 1.17 (middle
broken line), while the limits of agreement (upper and lower broken lines) were
3.59 and −1.25 respectively.
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levels. However, our analyses were performed on samples that
had been previously frozen and thawed prior to storage at 4 °C.
At the time of original collection BAL was put immediately
onto ice for transport to the laboratory and processed within 1 h.
The processing included centrifugation, removal and aliquoting
of the supernatant and freezing at −80 °C. The results of the
present study should not be taken to indicate that a BAL sample
could be stored at 4 °C before processing.
A previous report has shown that NE levels in gingival
crevicular fluid are unaffected for at least three days in storage at
−80 °C [17]. In BAL fluid, the data from the present study show
that NE levels remain stable for up to 6 months at −80 °C but
decreases after storage for 2 and 4 years. This may not reflect
the true nature of the enzymes integrity, as many of the samples
in the tested sets fell below the minimum detection limit, similar
to the issue with the 6 month group of IL-8 samples at −80 °C
mentioned above. Inter-assay variations are exaggerated the
most at the upper and lower limits of detection where values are
extrapolated, and with the majority of the NE results calculated
at these limits, some of the interpretations may be spurious. In
addition, no sample that initially had detectable NE activity fell
below the limit of detection after storage at −80 °C.
Neutrophil elastase has been shown to remain relatively stable at
4 °C for up to 24 h in blood samples [11] but no studies exist for
stability beyond this point or in BAL fluid. The present study
indicates a significant decrease in NE after seven days at 4 °C,
although once again the majority of the samples tested were below
the minimum detection limit of the assay at both the initial and
follow up time point. In addition, 6 samples that had detectable NE
when first tested fell below the limit of detection after storage at
4 °C. A fall in elastase activity in storage is not surprising. Sincewe
only measured the concentration by the level of activity, it is
possible that the NE itself may still be present in each sample intact,
but lacking any enzymatic functions.
We must place a caveat on the interpretation of the data from
the present study. None of our samples were assayed for either
IL-8 or NE fresh when originally collected. All samples had
been frozen at −80 °C for approximately one month prior to the
initial analysis. We cannot therefore exclude the possibility that
some initial degradation occurred.
In summary, for long-term archiving and longitudinal
analysis, researchers measuring IL-8 in BAL can confidently
keep samples at −80 °C for 6 years with no loss of integrity, and
the trends in our data suggest it may be possible for the storage
limit to extend beyond even this. IL-8 is also stable under
refrigerated conditions, presenting more flexibility of time with
a safe short-term storage option. The stability of NE in BAL at
−80 °C is less certain, but storage for 6 months at −80 °C
seems reasonable. Clearly BAL samples kept at 4 °C are at risk
of degradation. The safest option for analysis would be a prompt
measurement on or about the time of collection.
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